Oliver A. Cornely
- Infectious Diseases top 0.01%
- Antifungal resistance and susceptibility 323
- Clostridium difficile and Clostridium perfringens research 39
- Epidemiology top 0.02%
- Fungal Infections and Studies 257
- Pneumocystis jirovecii pneumonia detection and treatment 57
- Microscopic Colitis 33
- Small Animals top 0.05%
- Infectious Diseases and Mycology 64
-
- Neutropenia and Cancer Infections 87
-
- Plant Pathogens and Fungal Diseases 45
- Co-authors
- Jörg Janne VehreschildAndrew J. UllmannJohan MaertensPhilipp KoehlerMartin HoeniglThomas J. WalshGeorg MaschmeyerCornelia Lass‐Flörl
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Oliver A. Cornely
517 papers receiving 20.9k citations
Hit Papers
Peers
Comparison fields: 5 of 170
- Infectious Diseases 16.5k
- Epidemiology 14.2k
- Applied Microbiology and Biotechnology 677
- Small Animals 1.6k
- Critical Care and Intensive Care Medicine 778
Countries citing papers authored by Oliver A. Cornely
This map shows the geographic impact of Oliver A. Cornely's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oliver A. Cornely with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oliver A. Cornely more than expected).
Fields of papers citing papers by Oliver A. Cornely
This network shows the impact of papers produced by Oliver A. Cornely. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oliver A. Cornely. The network helps show where Oliver A. Cornely may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Oliver A. Cornely, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 3 | |
| 6 | 2023 | 7 | |
| 7 | 2023 | 0 | |
| 8 | 2023 | 42 | |
| 9 | 2023 | 11 | |
| 10 | 2023 | 1 | |
| 11 | 2023 | 11 | |
| 12 | 2021 | 6 | |
| 13 | 2021 | 12 | |
| 14 | 2018 | 6 | |
| 15 | 2017 | 30 | |
| 16 | 2015 | 21 | |
| 17 | 2015 | 25 | |
| 18 | 2014 | 81 | |
| 19 | Vancomycin, Metronidazole, or Tolevamer for Clostridium difficile Infection: Results From Two Multinational, Randomized, Controlled Trialsbreakdown → | 2014 | 394 |
| 20 | 2009 | 64 |
About Oliver A. Cornely
Oliver A. Cornely is a scholar working on Infectious Diseases, Epidemiology and Small Animals, having authored 546 papers that have together received 21.3k indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (323 papers), Fungal Infections and Studies (257 papers), Neutropenia and Cancer Infections (87 papers), Infectious Diseases and Mycology (64 papers), Pneumocystis jirovecii pneumonia detection and treatment (57 papers), Plant Pathogens and Fungal Diseases (45 papers), Clostridium difficile and Clostridium perfringens research (39 papers) and Microscopic Colitis (33 papers). The work is most often cited by research in Infectious Diseases (16.5k citations), Epidemiology (14.2k citations) and Applied Microbiology and Biotechnology (677 citations). Oliver A. Cornely has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Jörg Janne Vehreschild, Andrew J. Ullmann, Johan Maertens, Philipp Koehler, Martin Hoenigl, Thomas J. Walsh, Georg Maschmeyer, Cornelia Lass‐Flörl, Maria J. G. T. Vehreschild and John R. Perfect. Their work appears in journals such as New England Journal of Medicine, The Lancet and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.